{"id":30230,"date":"2017-05-22T11:14:40","date_gmt":"2017-05-22T10:14:40","guid":{"rendered":"http:\/\/blog.cofb.cat\/?p=30230"},"modified":"2017-05-22T11:14:40","modified_gmt":"2017-05-22T10:14:40","slug":"formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca","status":"publish","type":"post","link":"https:\/\/www.cofb.org\/es\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/","title":{"rendered":"Formaciones COFB: \u00bfcu\u00e1les son las patolog\u00edas oftalmol\u00f3gicas de mayor prevalencia?"},"content":{"rendered":"<p>La elevada prevalencia de las patolog\u00edas oftalmol\u00f3gicas y las alteraciones oculares genera un problema de salud sociosanitario, tanto porque algunas van ligadas al envejecimiento de la poblaci\u00f3n como es el caso del glaucoma, de las cataratas y de la degeneraci\u00f3n macular asociada a la edad (DMAE), como un problema de cronicidad o incluso de discapacidad o ceguera. En la farmacia, las afecciones oculares son patolog\u00edas de consulta muy frecuente.<\/p>\n<figure id=\"attachment_30237\" aria-describedby=\"caption-attachment-30237\" style=\"width: 298px\" class=\"wp-caption alignright\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/patologies-oftalmologiques-COFB-2.jpg\"><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-30237\" alt=\"patologies-oftalmologiques-COFB (2)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/patologies-oftalmologiques-COFB-2.jpg\" width=\"298\" height=\"199\" \/><\/a><figcaption id=\"caption-attachment-30237\" class=\"wp-caption-text\">Pablo Iniesta (Servicio de Oftalmolog\u00eda del Hospital de Manresa), uno de los docentes del curso<\/figcaption><\/figure>\n<p>El curso \u201c<b>Patolog\u00edas oftalmol\u00f3gicas de mayor prevalencia y otras alteraciones oculares<\/b>\u201d que tuvo lugar en el COFB los d\u00edas 25 y 27 de abril, trat\u00f3 los diferentes tratamientos farmacol\u00f3gicos de las patolog\u00edas y las alteraciones oculares que a menudo son consultadas en el farmac\u00e9utico y tambi\u00e9n de las medidas de prevenci\u00f3n y de recomendaci\u00f3n para mantener una buena salud ocular y mejorar el consejo y la atenci\u00f3n farmac\u00e9utica oftalmol\u00f3gica.<\/p>\n<p>Los alumnos asistentes aprendieron a reconocer la sintomatolog\u00eda com\u00fan y diferencial de cada una de las patolog\u00edas que abordaba el curso, los tratamientos farmacol\u00f3gicos asociados y supieron c\u00f3mo aconsejar las medidas de prevenci\u00f3n y de recomendaci\u00f3n sanitaria y c\u00f3mo hacer una correcta atenci\u00f3n farmac\u00e9utica e identificar cu\u00e1ndo es necesario derivar al especialista.<\/p>\n<div class=\"box shadow\">\u201c<b>Una de las funciones m\u00e1s importantes del farmac\u00e9utico es asegurar que el paciente ha entendido perfectamente c\u00f3mo debe administrarse el colirio, porque es fundamental para una correcta adherencia al tratamiento, as\u00ed como conocer todos los medicamentos que est\u00e1n contraindicados en aquellos pacientes que sufren glaucoma<\/b>\u201d explica <b>Cristina Rodr\u00edguez<\/b>, jefe del departamento de Formaci\u00f3n del Colegio y coordinadora del curso. Y a\u00f1ade: \u201cOtro aspecto que se ha puesto de manifiesto en el curso es que <strong>no deben indicarse colirios con corticoides o pomadas antibi\u00f3ticas a menos que se tenga la certeza de su indicaci\u00f3n, ya que, en caso contrario, pueden enmascarar la patolog\u00eda, dificultando la labor del especialista<\/strong>. Todos estos aspectos, junto a las medidas de prevenci\u00f3n y recomendaci\u00f3n para mantener una buena salud ocular, nos permitir\u00e1n mejorar el consejo y la atenci\u00f3n farmac\u00e9utica oftalmol\u00f3gica\u201d.<\/div>\n<p>El programa del curso hizo un repaso a los tipos de conjuntivitis (v\u00edricas, bacterianas, al\u00e9rgicas, blefaroconjuntivitis, qu\u00edmicas, irritativas, por enfermedades sist\u00e9micas, etc.), el glaucoma y degeneraci\u00f3n macular asociada a la edad (DMAE), las cataratas, la retinopat\u00eda diab\u00e9tica, las alteraciones del sistema lagrimal, las enfermedades de los p\u00e1rpados y otras alteraciones oculares. Tambi\u00e9n se facilitaron recomendaciones de salud ocular en la infancia, la edad adulta y en las personas mayores.<\/p>\n<p>El cuadro docente lo formaron <b>Pablo Infiesta<\/b> del Servicio de Oftalmolog\u00eda del Hospital de Manresa, y<b> Sandra G\u00f3mez <\/b>del Servicio de Oftalmolog\u00eda del Hospital Universitario Germans Trias i Pujol de Badalona.<\/p>\n<p style=\"text-align: center;\"><a href=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/patologies-oftalmologiques-COFB-1.jpg\"><img decoding=\"async\" class=\"size-large wp-image-30236 aligncenter\" alt=\"patologies-oftalmologiques-COFB (1)\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/patologies-oftalmologiques-COFB-1-1024x534.jpg\" width=\"620\" height=\"323\" \/><\/a><\/p>\n<p>&nbsp;<\/p>\n<p align=\"right\"><b>Con la colaboraci\u00f3n de:<\/b><\/p>\n<p align=\"right\"><a href=\"https:\/\/www.angelini.es\/\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" class=\"alignright  wp-image-30235\" alt=\"ANGELINI-logo\" src=\"http:\/\/blog.cofb.cat\/wp-content\/uploads\/2017\/05\/ANGELINI-logo.jpg\" width=\"116\" height=\"128\" \/><\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>La elevada prevalencia de las patolog\u00edas oftalmol\u00f3gicas y las alteraciones oculares genera un problema de salud sociosanitario, tanto porque algunas van ligadas al envejecimiento de la poblaci\u00f3n como es el caso del glaucoma, de las cataratas y de la degeneraci\u00f3n macular asociada a la edad (DMAE), como un problema de cronicidad [\u2026]<\/p>","protected":false},"author":1,"featured_media":30238,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"disabled","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[57],"tags":[2763,2764,64,2765,2766,2767,69,2228,2768,2769,2770,2771,2772,2773],"class_list":["post-30230","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mon-collegial","tag-alteracions-del-sistema-lacrimal","tag-alteracions-oculars","tag-atencio-farmaceutica","tag-catarates","tag-conjuntivitis","tag-dmae","tag-farmacia-comunitaria","tag-gent-gran","tag-glaucoma","tag-malalties-de-les-parpelles","tag-oftalmologia","tag-patologies-oftalmologiques","tag-retinopatia-diabetica","tag-salut-ocular"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?<\/title>\n<meta name=\"description\" content=\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\" \/>\n<meta property=\"og:description\" content=\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\" \/>\n<meta property=\"og:url\" content=\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\" \/>\n<meta property=\"og:site_name\" content=\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-05-22T10:14:40+00:00\" \/>\n<meta name=\"author\" content=\"wpAdminCofbOrg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:site\" content=\"@farmaceuticsbcn\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"wpAdminCofbOrg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\"},\"author\":{\"name\":\"wpAdminCofbOrg\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\"},\"headline\":\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\",\"datePublished\":\"2017-05-22T10:14:40+00:00\",\"dateModified\":\"2017-05-22T10:14:40+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\"},\"wordCount\":522,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage\"},\"thumbnailUrl\":\"\",\"keywords\":[\"alteracions del sistema lacrimal\",\"alteracions oculars\",\"Atenci\u00f3 farmac\u00e8utica\",\"catarates\",\"conjuntivitis\",\"DMAE\",\"farm\u00e0cia comunit\u00e0ria\",\"gent gran\",\"glaucoma\",\"malalties de les parpelles\",\"oftalmologia\",\"patologies oftalmol\u00f2giques\",\"retinopatia diab\u00e8tica\",\"salut ocular\"],\"articleSection\":[\"M\u00f3n col\u00b7legial\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\",\"url\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\",\"name\":\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\",\"isPartOf\":{\"@id\":\"https:\/\/www.cofb.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage\"},\"thumbnailUrl\":\"\",\"datePublished\":\"2017-05-22T10:14:40+00:00\",\"dateModified\":\"2017-05-22T10:14:40+00:00\",\"description\":\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\",\"breadcrumb\":{\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage\",\"url\":\"\",\"contentUrl\":\"\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Inici\",\"item\":\"https:\/\/novaorg.cofb.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.cofb.org\/#website\",\"url\":\"https:\/\/www.cofb.org\/\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.cofb.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.cofb.org\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.cofb.org\/#organization\",\"name\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\",\"url\":\"https:\/\/www.cofb.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"contentUrl\":\"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png\",\"width\":500,\"height\":105,\"caption\":\"Col\u00b7legi de Farmac\u00e8utics de Barcelona\"},\"image\":{\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/farmaceuticsbcn\/\",\"https:\/\/twitter.com\/farmaceuticsbcn\",\"https:\/\/www.instagram.com\/farmaceuticsbcn\/\",\"https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb\",\"name\":\"wpAdminCofbOrg\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.cofb.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g\",\"caption\":\"wpAdminCofbOrg\"},\"sameAs\":[\"http:\/\/192.168.64.122\/wordpress\"],\"url\":\"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","description":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/","og_locale":"es_ES","og_type":"article","og_title":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","og_description":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","og_url":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/","og_site_name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","article_publisher":"https:\/\/www.facebook.com\/farmaceuticsbcn\/","article_published_time":"2017-05-22T10:14:40+00:00","author":"wpAdminCofbOrg","twitter_card":"summary_large_image","twitter_creator":"@farmaceuticsbcn","twitter_site":"@farmaceuticsbcn","twitter_misc":{"Escrito por":"wpAdminCofbOrg","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#article","isPartOf":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/"},"author":{"name":"wpAdminCofbOrg","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb"},"headline":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","datePublished":"2017-05-22T10:14:40+00:00","dateModified":"2017-05-22T10:14:40+00:00","mainEntityOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/"},"wordCount":522,"commentCount":0,"publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage"},"thumbnailUrl":"","keywords":["alteracions del sistema lacrimal","alteracions oculars","Atenci\u00f3 farmac\u00e8utica","catarates","conjuntivitis","DMAE","farm\u00e0cia comunit\u00e0ria","gent gran","glaucoma","malalties de les parpelles","oftalmologia","patologies oftalmol\u00f2giques","retinopatia diab\u00e8tica","salut ocular"],"articleSection":["M\u00f3n col\u00b7legial"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/","url":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/","name":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","isPartOf":{"@id":"https:\/\/www.cofb.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage"},"image":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage"},"thumbnailUrl":"","datePublished":"2017-05-22T10:14:40+00:00","dateModified":"2017-05-22T10:14:40+00:00","description":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?","breadcrumb":{"@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#primaryimage","url":"","contentUrl":""},{"@type":"BreadcrumbList","@id":"https:\/\/novaorg.cofb.net\/2017\/05\/22\/formacions-cofb-quines-son-les-patologies-oftalmologiques-de-mes-prevalenca\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Inici","item":"https:\/\/novaorg.cofb.net\/"},{"@type":"ListItem","position":2,"name":"Formacions COFB: quines s\u00f3n les patologies oftalmol\u00f2giques de m\u00e9s prevalen\u00e7a?"}]},{"@type":"WebSite","@id":"https:\/\/www.cofb.org\/#website","url":"https:\/\/www.cofb.org\/","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","description":"","publisher":{"@id":"https:\/\/www.cofb.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cofb.org\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.cofb.org\/#organization","name":"Col\u00b7legi de Farmac\u00e8utics de Barcelona","url":"https:\/\/www.cofb.org\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","contentUrl":"https:\/\/www.cofb.org\/wp-content\/uploads\/2023\/11\/cropped-Logotip-COFB.png","width":500,"height":105,"caption":"Col\u00b7legi de Farmac\u00e8utics de Barcelona"},"image":{"@id":"https:\/\/www.cofb.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/farmaceuticsbcn\/","https:\/\/twitter.com\/farmaceuticsbcn","https:\/\/www.instagram.com\/farmaceuticsbcn\/","https:\/\/www.linkedin.com\/company\/farmaceuticsbcn\/"]},{"@type":"Person","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/22ed7eea88da74b0fa4d3154ad87ffcb","name":"wpAdminCofbOrg","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.cofb.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1721b20b3b8ca882c3b56ec6c978c594fff670e40c0718e9190eaeeb76aae7d8?s=96&d=mm&r=g","caption":"wpAdminCofbOrg"},"sameAs":["http:\/\/192.168.64.122\/wordpress"],"url":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"}]}},"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"trp-custom-language-flag":false},"uagb_author_info":{"display_name":"wpAdminCofbOrg","author_link":"https:\/\/www.cofb.org\/es\/author\/wpadmincofborg\/"},"uagb_comment_info":0,"uagb_excerpt":"La prevalen\u00e7a elevada de les patologies oftalmol\u00f2giques i les alteracions oculars genera un problema de salut sociosanitari, tant perqu\u00e8 algunes van lligades a l\u2019envelliment de la poblaci\u00f3 com \u00e9s el cas del glaucoma, de les cataractes i de la degeneraci\u00f3 macular associada a l\u2019edat (DMAE), com un problema de cronicitat [&hellip;]","_links":{"self":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/30230","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/comments?post=30230"}],"version-history":[{"count":0,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/posts\/30230\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/"}],"wp:attachment":[{"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/media?parent=30230"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/categories?post=30230"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.cofb.org\/es\/wp-json\/wp\/v2\/tags?post=30230"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}